Has Thomas Pitts, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,044 in general payments to Thomas Pitts, MD across 633 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Pitts, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Pitts, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Pitts, MD

Endocrinology, Diabetes & Metabolism · Chicago, ILNPI 1730146671

Payments from drug & device makers

$29,044in general payments, 2019–2025

Across 633 payments — averaging $45.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi US Services Inc.$9K
Amarin Pharma, Inc.$6K
Lexicon Pharmaceuticals, Inc.$2K
Novo Nordisk$2K
Boehringer Ingelheim$1K
AstraZeneca$1K
plus $8K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi US Services Inc.	9	$9,404
Amarin Pharma, Inc.	7	$5,543
Lexicon Pharmaceuticals, Inc.	1	$2,019
Novo Nordisk	108	$1,651
Boehringer Ingelheim	60	$1,482
AstraZeneca(2 entities)	59	$1,369
Lilly USA, LLC	45	$953
Mannkind Corporation	41	$839
Sanofi-aventis U.S. LLC	40	$741
Merck	46	$710
AbbVie	28	$489
Dexcom, Inc.	17	$401
Corcept Therapeutics	20	$366
Amgen(2 entities)	21	$356
IBSA Pharma Inc.	15	$269
Johnson & Johnson	13	$252
Intuity Medical Inc	8	$238
Medtronic	3	$231
Xeris Pharmaceuticals, Inc.	11	$212
Arbor Pharmaceuticals, Inc.	13	$200
Sanofi Pasteur Inc.	10	$150
Vivus LLC	8	$137
Bayer	6	$136
Lifescan, Inc.	4	$124
Abbott	6	$106
Pfizer	5	$88
Shire North American Group Inc	4	$75
Esperion Therapeutics, Inc.	3	$59
Cequr Corporation	2	$59
Novartis	2	$47
Kowa Pharmaceuticals America, Inc.	3	$44
Tandem Diabetes Care, Inc.	1	$43
Insulet Corporation	2	$40
Azurity Pharmaceuticals, Inc.	2	$38
Amneal Pharmaceuticals LLC	2	$35
Aegerion Pharmaceuticals, Inc.	2	$30
Amryt Pharma Holdings Ltd	1	$24
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Radius Health, Inc.	1	$19
Ultragenyx Pharmaceutical Inc.	1	$17
Hikma Pharmaceuticals USA	1	$14
Vistapharm, Inc.	1	$12

How this compares

$29,044 in reported general payments places this provider in the 85th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.

See all endocrinology, diabetes & metabolism providers in Illinois →

Medicare billing

Part B allowed, 2024

$29,490

Medicare patients

Services billed

254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Chicago

Leon FogelfeldChicago$1.5M
Grazia AleppoChicago$1.4M
Wahid KassarChicago$884K
Wenyu HuangChicago$639K
Silvana PannainChicago$575K
Tamara VokesChicago$448K
George BakrisChicago$429K
William LoweChicago$372K
Rajesh JainChicago$285K
Louis PhilipsonChicago$236K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →